[Experience with the combined treatment of recurrent herpes using larifan and a herpetic vaccine].
Interferon inductor larifan used parenterally was combined with herpetic vaccine to treat severe recurrent herpes in 32 patients. This combination therapy started at initiation of herpetic infection activation and resulted in amelioration of the clinical symptoms of the recurrence, a more favourable course of the disease due to stimulation of the interferon system and natural killer activity. In combination the above modalities proved more effective than in monotherapy.
Potekaev
N S
NS
Nosik
N N
NN
Samgin
M A
MA
Kudratullaev
K N
KN
Lavrukhina
L A
LA
D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D004341:Drug Evaluation; D005260:Female; D006561:Herpes Simplex / Q000628:therapy*; D006801:Humans; D007369:Interferon Inducers / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009930:Organic Chemicals; D012008:Recurrence; D012074:Remission Induction; D018139:Simplexvirus / Q000276:immunology*; D013997:Time Factors; D014765:Viral Vaccines / Q000627:therapeutic use*
D000998:Antiviral Agents; D007369:Interferon Inducers; D009930:Organic Chemicals; D014765:Viral Vaccines; C066530:larifan
Opyt kombinirovannogo lecheniia retsidiviruiushchego gerpesa larifanom i gerpeticheskoĭ vaktsinoĭ.